Seelos Therapeutics, INC Form 4 insider transactions
Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.
OTC.Pink
Michael Joseph Golembiewski, CFO of Seelos Therapeutics, acquired 417 shares of common stock under the company's Employee Stock Purchase Plan on February 29, 2024.